Seminarios Vall d'Hebron: Avances en Enfermedades Lisosomales

 
  Hotel Alimara, C/Berruguete 126 - Barcelona 08035 —
03/05/2019
03/05/2019 -- From 09:00h to 18:00h
Organize :
Unidad de Enfermedades Metabólicas HereditariasUnidad de Enfermedades Minoritarias
Modality: Presencial
Share it:

9:00-9:15 – Opening

9:15-10.45– New treatments for old diseases
Chair: Dra. Mar O’Callaghan, Hospital Sant Joan de Déu, Barcelona 

Dra. Mireia del Toro, Hospital Vall d’Hebron, Barcelona "Lipofuscinosis: importance of early diagnosis and treatment"

Dr. Jesús Villarrubia, Hospital Ramón y Cajal, Madrid "Niemann-Pick type B: new therapeutic opportunities"

Dr. Antonio González Meneses, Hospital Virgen del Rocío, Sevilla "Update in diagnosis and treatment of the mucopolysaccharidosis"
 
10.45-11:15 – Coffee break
 
11:15-12.45 – New diagnostic approaches and research therapeutic strategies 
Chair: Dr. José Antonio Arranz, Hospital Vall d’Hebron, Barcelona

Dr. Cristóbal Colón, Hospital Universitario, Santiago de Compostela "Present situation of the newborn screening for lysosomal diseases"

Dra. Ibane Abasolo, CIBBIM-Nanomedicina, Institut Recerca Vall d’Hebron, Barcelona "Therapeutic applications of extracellular vesicles as vehicles for lysosomal enzymes"

Dr. Víctor Álvarez, Hospital Universitario, Santiago de Compostela  "Vehículos no virales: nueva aplicación para MPS IV"                             

Dra. Silvia Muro, University of Maryland (USA), ICREA - Institut de Bioingenieria de Catalunya, Barcelona "New means to enable blood-to-brain access of lysosomal enzyme therapies"
  
13:00 – 14:00 Buffet/Lunch
  
14:00-16:30 – Treatment and long-term evolution of Gaucher and Fabry diseases
Chairs: Dr. Xavier Solanich, Hospital Bellvitge, and Dr. VicençTorregrosa, Hospital Clínic

Dr. Derralynn Hughes, Royal Free Hospital, UCL, London (UK) "Bone disease and malignancy in Gaucherdisease"

Dr. Gregory Pastores, University College Dublin , Ireland "Guidelines and therapeutic goals in Gaucherdisease"

Dr. Roser Torra, FundacióPuigvert, Barcelona "Early detection and long-term evolution of Fabrynephropathy" 

Dr. Guillem Pintos, Hospital UniversitariValld’Hebron, Barcelona 2Clinical phenotype and genotype in the management of young Fabrypatients"

Dr. Derralynn Hughes, Royal Free Hospital, UCL ,London (UK)  2How to diagnose and treat female Fabrypatients"

 

Inscripcions clicant en aquest enllaç

Més Informació:  Direcció de Comunicació, Màrqueting i RSC - Vall d’Hebron Barcelona Hospital Campus

comunica@vhir.org

 

 

Subscribe to our newsletters and be a part of Campus Life

Select the newsletter you want to receive:

By accepting these conditions, you are agreeing to the processing of your personal data for the provision of the services requested through this portal, and, if necessary, for any procedures required by the administrations or public bodies involved in this processing, and their subsequent inclusion in the aforementioned automated file. You may exercise your rights to access, rectification, cancellation or opposition by writing to web@vallhebron.cat, clearly stating the subject as "Exercising of Data Protection Rights".
Operated by: Hospital Universitari Vall d'Hebron - Institut Català de la Salut.
Purpose: Manage the user’s contact information.
Legitimisation: Express acceptance of the privacy policy.
Rights: To access, rectify, and delete personal information data, as well to the portability thereof and to limit and/or oppose their use.
Source: The interested party themselves.